Clinical Trials Directory

Trials / Completed

CompletedNCT03144570

EURopean Study on Encephalitis in Intensive CAre

Status
Completed
Phase
Study type
Observational
Enrollment
596 (actual)
Sponsor
ICUREsearch · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective observational multicenter study in European ICUs. All patients admitted to the ICU for probable or confirmed Acute encephalitis (2013 IDSA - Infectious Disease Society of America criteria) will be included. Factors associated with a poor prognosis will be identified by multivariate analysis using a logistic regression.

Detailed description

Primary objective : evaluate the correlation between mRs score and the baseline characteristics Functional outcomes will be evaluated using the modified Rankin score (mRS) score, which is one of the most frequently used scores in acute neurological diseases \[18\]. A poor outcome will be defined by a mRS score \> 2 (functional dependence or death). The investigator usually evaluates this score if the patient is still in the hospital 90 days after admission. Patients discharged from hospital within 90 days following ICU admission without major disability (mRS 0, 1 or 2) are considered to have a good outcome. Patients discharged within 90 days with a disability will be classified for the study according to the latest available data. Patients will not be contacted directly by the investigator for the study purposes. Secondary objectives : To identify additional prognosis factors : the clinical, radiological, biological and neurophysiological factors associated with poor outcome for patients admitted to the ICU with AE * Day 28 mortality, in-ICU mortality, in-hospital mortality * Major systemic complications (septic shock, hyponatremia, nosocomial pneumonia, catheter-related BSI, overt gastroenteral bleeding, pulmonary embolism) * Major intracranial complications during ICU stay * Status epilepticus * Brain death * Empyema/cerebral abscess * Cerebral ischemia * Intracranial bleeding * ICP monitoring * Neurosurgery The cause of death will be categorized into 2 categories: * Systemic causes (cardiovascular failure, MOF) * Neurological cause (Diffuse neurologic injury or withdrawal of care)

Conditions

Interventions

TypeNameDescription
OTHERNone, non-interventional studyNot applicable, non-interventional study

Timeline

Start date
2017-06-01
Primary completion
2020-07-06
Completion
2020-12-31
First posted
2017-05-09
Last updated
2021-04-01

Locations

65 sites across 6 countries: Austria, France, India, Italy, Netherlands, Spain

Source: ClinicalTrials.gov record NCT03144570. Inclusion in this directory is not an endorsement.